Literature DB >> 24002445

Transcriptional regulation of the Ikzf1 locus.

Toshimi Yoshida1, Esther Landhuis, Marei Dose, Idit Hazan, Jiangwen Zhang, Taku Naito, Audrey F Jackson, Jeffrey Wu, Elizabeth A Perotti, Christoph Kaufmann, Fotini Gounari, Bruce A Morgan, Katia Georgopoulos.   

Abstract

Ikaros is a critical regulator of lymphocyte development and homeostasis; thus, understanding its transcriptional regulation is important from both developmental and clinical perspectives. Using a mouse transgenic reporter approach, we functionally characterized a network of highly conserved cis-acting elements at the Ikzf1 locus. We attribute B-cell and myeloid but not T-cell specificity to the main Ikzf1 promoter. Although this promoter was unable to counter local chromatin silencing effects, each of the 6 highly conserved Ikzf1 intronic enhancers alleviated silencing. Working together, the Ikzf1 enhancers provided locus control region activity, allowing reporter expression in a position and copy-independent manner. Only 1 of the Ikzf1 enhancers was responsible for the progressive upregulation of Ikaros expression from hematopoietic stem cells to lymphoid-primed multipotent progenitors to T-cell precursors, which are stages of differentiation dependent on Ikaros for normal outcome. Thus, Ikzf1 is regulated by both epigenetic and transcriptional factors that target its enhancers in both redundant and specific fashions to provide an expression profile supportive of normal lymphoid lineage progression and homeostasis. Mutations in the Ikzf1 regulatory elements and their interacting factors are likely to have adverse effects on lymphopoiesis and contribute to leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24002445      PMCID: PMC3814732          DOI: 10.1182/blood-2013-01-474916

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

1.  Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment.

Authors:  K Georgopoulos; D D Moore; B Derfler
Journal:  Science       Date:  1992-10-30       Impact factor: 47.728

Review 2.  Transcription factors required for lymphoid lineage commitment.

Authors:  K Georgopoulos
Journal:  Curr Opin Immunol       Date:  1997-04       Impact factor: 7.486

3.  Ikaros sets thresholds for T cell activation and regulates chromosome propagation.

Authors:  N Avitahl; S Winandy; C Friedrich; B Jones; Y Ge; K Georgopoulos
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

4.  A large fraction of extragenic RNA pol II transcription sites overlap enhancers.

Authors:  Francesca De Santa; Iros Barozzi; Flore Mietton; Serena Ghisletti; Sara Polletti; Betsabeh Khoramian Tusi; Heiko Muller; Jiannis Ragoussis; Chia-Lin Wei; Gioacchino Natoli
Journal:  PLoS Biol       Date:  2010-05-11       Impact factor: 8.029

5.  Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells.

Authors:  Samuel Yao-Ming Ng; Toshimi Yoshida; Jiangwen Zhang; Katia Georgopoulos
Journal:  Immunity       Date:  2009-04-02       Impact factor: 31.745

6.  T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling.

Authors:  Kristine Germar; Marei Dose; Tassos Konstantinou; Jiangwen Zhang; Hongfang Wang; Camille Lobry; Kelly L Arnett; Stephen C Blacklow; Iannis Aifantis; Jon C Aster; Fotini Gounari
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-22       Impact factor: 11.205

7.  A user's guide to the encyclopedia of DNA elements (ENCODE).

Authors: 
Journal:  PLoS Biol       Date:  2011-04-19       Impact factor: 8.029

8.  Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros.

Authors:  S Winandy; L Wu; J H Wang; K Georgopoulos
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

9.  Asymmetrical lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors.

Authors:  Anne Y Lai; Motonari Kondo
Journal:  J Exp Med       Date:  2006-07-31       Impact factor: 14.307

10.  Harnessing of the nucleosome-remodeling-deacetylase complex controls lymphocyte development and prevents leukemogenesis.

Authors:  Jiangwen Zhang; Audrey F Jackson; Taku Naito; Marei Dose; John Seavitt; Feifei Liu; Elizabeth J Heller; Mariko Kashiwagi; Toshimi Yoshida; Fotini Gounari; Howard T Petrie; Katia Georgopoulos
Journal:  Nat Immunol       Date:  2011-11-13       Impact factor: 25.606

View more
  22 in total

1.  Ikaros: the enhancer makes the difference.

Authors:  Sinisa Dovat
Journal:  Blood       Date:  2013-10-31       Impact factor: 22.113

2.  Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study.

Authors:  J M Boer; A van der Veer; D Rizopoulos; M Fiocco; E Sonneveld; H A de Groot-Kruseman; R P Kuiper; P Hoogerbrugge; M Horstmann; M Zaliova; C Palmi; J Trka; E Fronkova; M Emerenciano; M do Socorro Pombo-de-Oliveira; W Mlynarski; T Szczepanski; K Nebral; A Attarbaschi; N Venn; R Sutton; C J Schwab; A Enshaei; A Vora; M Stanulla; M Schrappe; G Cazzaniga; V Conter; M Zimmermann; A V Moorman; R Pieters; M L den Boer
Journal:  Leukemia       Date:  2015-07-23       Impact factor: 11.528

3.  Age-associated DNA methylation changes in naive CD4+ T cells suggest an evolving autoimmune epigenotype in aging T cells.

Authors:  Mikhail G Dozmorov; Patrick Coit; Kathleen Maksimowicz-McKinnon; Amr H Sawalha
Journal:  Epigenomics       Date:  2017-03-21       Impact factor: 4.778

4.  Variations in mRNA and protein levels of Ikaros family members in pediatric T cell acute lymphoblastic leukemia.

Authors:  Julie L Mitchell; Thomas M Yankee
Journal:  Ann Transl Med       Date:  2016-10

5.  Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant patients differs by age and sex.

Authors:  Alyssa I Clay-Gilmour; Theresa Hahn; Leah M Preus; Kenan Onel; Andrew Skol; Eric Hungate; Qianqian Zhu; Christopher A Haiman; Daniel O Stram; Loreall Pooler; Xin Sheng; Li Yan; Qian Liu; Qiang Hu; Song Liu; Sebastiano Battaglia; Xiaochun Zhu; AnneMarie W Block; Sheila N J Sait; Ezgi Karaesmen; Abbas Rizvi; Daniel J Weisdorf; Christine B Ambrosone; David Tritchler; Eva Ellinghaus; David Ellinghaus; Martin Stanulla; Jacqueline Clavel; Laurent Orsi; Stephen Spellman; Marcelo C Pasquini; Philip L McCarthy; Lara E Sucheston-Campbell
Journal:  Blood Adv       Date:  2017-09-08

6.  Selected miRNA levels are associated with IKZF1 microdeletions in pediatric acute lymphoblastic leukemia.

Authors:  J Krzanowski; J Madzio; A Pastorczak; A Tracz; M Braun; J Tabarkiewicz; A Pluta; W Młynarski; I Zawlik
Journal:  Oncol Lett       Date:  2017-07-18       Impact factor: 2.967

7.  Hepatocyte Growth Factor Improves the Therapeutic Efficacy of Human Bone Marrow Mesenchymal Stem Cells via RAD51.

Authors:  Eun Ju Lee; Injoo Hwang; Ji Yeon Lee; Jong Nam Park; Keun Cheon Kim; Gi-Hwan Kim; Chang-Mo Kang; Irene Kim; Seo-Yeon Lee; Hyo-Soo Kim
Journal:  Mol Ther       Date:  2017-12-19       Impact factor: 11.454

8.  Ikaros imposes a barrier to CD8+ T cell differentiation by restricting autocrine IL-2 production.

Authors:  Shaun O'Brien; Rajan M Thomas; Gerald B Wertheim; Fuqin Zhang; Hao Shen; Andrew D Wells
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

9.  Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia.

Authors:  Chunhua Song; Chandrika Gowda; Xiaokang Pan; Yali Ding; Yongqing Tong; Bi-Hua Tan; Haijun Wang; Sunil Muthusami; Zheng Ge; Mansi Sachdev; Shantu G Amin; Dhimant Desai; Krishne Gowda; Raghavendra Gowda; Gavin P Robertson; Hilde Schjerven; Markus Muschen; Kimberly J Payne; Sinisa Dovat
Journal:  Blood       Date:  2015-07-28       Impact factor: 22.113

Review 10.  Ikaros fingers on lymphocyte differentiation.

Authors:  Toshimi Yoshida; Katia Georgopoulos
Journal:  Int J Hematol       Date:  2014-08-02       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.